![Dennis Hom](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dennis Hom
Director of Finance/CFO at
PROQR THERAPEUTICS N.V.
Profile
Dennis Hom currently works at ProQR Therapeutics NV, as Chief Financial Officer from 2025.
Mr. Hom also formerly worked at Amgen, Inc., as Executive Director-Corporate Development from 2011 to 2012, Achaogen, Inc., as Vice President-Finance & Corporate Development from 2013 to 2014, and Sagimet Biosciences, Inc., as CFO & Head-Corporate Development from 2017 to 2023.
Mr. Hom received his undergraduate degree from Massachusetts Institute of Technology.
Dennis Hom active positions
| Companies | Position | Start |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Director of Finance/CFO | 13/04/2025 |
Former positions of Dennis Hom
| Companies | Position | End |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Director of Finance/CFO | 31/07/2023 |
| ACHAOGEN | Director of Finance/CFO | 30/03/2014 |
| AMGEN INC. | Corporate Officer/Principal | 31/12/2011 |
Training of Dennis Hom
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
61
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Sagimet Biosciences, Inc.
 Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
ProQR Therapeutics NV
 ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
- Stock Market
- Insiders
- Dennis Hom
